MANDAS, ANTONELLA
 Distribuzione geografica
Continente #
EU - Europa 152.141
NA - Nord America 7.839
AS - Asia 3.899
SA - Sud America 474
AF - Africa 97
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 2
Totale 164.473
Nazione #
IT - Italia 149.511
US - Stati Uniti d'America 7.738
SG - Singapore 1.519
CN - Cina 1.354
UA - Ucraina 646
SE - Svezia 480
DE - Germania 360
BR - Brasile 359
VN - Vietnam 347
FI - Finlandia 284
GB - Regno Unito 282
FR - Francia 232
HK - Hong Kong 143
IN - India 122
NL - Olanda 91
KR - Corea 81
CA - Canada 56
RU - Federazione Russa 54
BD - Bangladesh 51
AR - Argentina 37
JP - Giappone 36
PL - Polonia 33
EC - Ecuador 30
IQ - Iraq 28
TR - Turchia 25
ZA - Sudafrica 25
AT - Austria 24
ES - Italia 23
IR - Iran 23
MX - Messico 21
BE - Belgio 20
IE - Irlanda 20
PH - Filippine 18
AU - Australia 16
ID - Indonesia 16
PK - Pakistan 16
SA - Arabia Saudita 15
MY - Malesia 14
NG - Nigeria 14
UZ - Uzbekistan 14
EG - Egitto 13
MA - Marocco 13
TH - Thailandia 13
CH - Svizzera 12
CO - Colombia 11
AL - Albania 9
GR - Grecia 9
OM - Oman 9
VE - Venezuela 9
LT - Lituania 8
CL - Cile 7
JO - Giordania 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
NP - Nepal 6
TN - Tunisia 6
TW - Taiwan 6
ET - Etiopia 5
LB - Libano 5
NZ - Nuova Zelanda 5
PE - Perù 5
PY - Paraguay 5
RO - Romania 5
UY - Uruguay 5
AZ - Azerbaigian 4
BH - Bahrain 4
HR - Croazia 4
MU - Mauritius 4
DZ - Algeria 3
HN - Honduras 3
JM - Giamaica 3
KE - Kenya 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LY - Libia 3
MD - Moldavia 3
PT - Portogallo 3
RS - Serbia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
BY - Bielorussia 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
LV - Lettonia 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
Totale 164.457
Città #
Cagliari 143.237
Uta 3.872
Singapore 835
Ashburn 681
Chandler 586
Fairfield 557
Woodbridge 511
San Jose 497
Ann Arbor 477
Boardman 449
Dallas 429
Jacksonville 346
Houston 332
Nyköping 290
Wilmington 283
Seattle 240
Beijing 204
Cambridge 200
Helsinki 176
Milan 175
Rome 174
Hefei 171
Hong Kong 131
Dearborn 127
Los Angeles 127
Council Bluffs 123
Santa Clara 114
Nanjing 105
Ho Chi Minh City 101
Boston 100
Lauterbourg 93
Shanghai 80
New York 73
Seoul 69
Hanoi 68
Sassari 63
Verona 61
Naples 55
Buffalo 53
Dong Ket 46
São Paulo 45
The Dalles 44
Turin 41
Shenyang 40
Frankfurt am Main 39
Bari 38
Hebei 34
Nanchang 32
Jiaxing 31
San Diego 31
Munich 29
Redwood City 29
Changsha 28
Pune 27
Zhengzhou 27
Tianjin 26
Tokyo 26
Guangzhou 25
London 25
Redondo Beach 25
Washington 24
Warsaw 22
Chicago 21
Orem 21
Genoa 19
Toronto 19
Brooklyn 18
Brussels 18
Da Nang 18
Jinan 18
Nuremberg 18
Orange 18
Phoenix 18
Rio de Janeiro 18
Amsterdam 17
Atlanta 17
Chennai 17
Bologna 16
Montreal 16
Mountain View 16
Auburn Hills 15
Baghdad 15
Bay Shore 15
Catania 15
Mumbai 15
Norwalk 15
Denver 14
Florence 14
Hangzhou 13
Porto Torres 13
Wuhan 13
Brescia 12
Guayaquil 12
Haiphong 12
Quito 12
Dublin 11
Gravina In Puglia 11
Stockholm 11
Vienna 11
Belo Horizonte 10
Totale 157.581
Nome #
null 3.998
Cognitive decline and depressive symptoms in late-life are associated with statin use: evidence from a population-based study of Sardinian old people living in their own home 3.389
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 3.191
null 3.087
A Determination of Neutral Lipid and Cluster Formation for Screening Neurocognitive Impairment in Human Immunodeficiency Virus Patients 3.008
null 2.985
null 2.897
Abnormal lipid accumulation and cluster formation of naive peripheral blood mononuclear cells: a useful tool for early detection of central nervous system damage in elderly 2.875
Resting-state functional connectivity MRI analysis in Human Immunodeficiency Virus and Hepatitis C Virus co-infected subjects. A pilot study 2.816
The venous thromboembolic risk and the clot wave analysis: a useful relationship? 2.768
ACAT-1, Cav-1 and PrP expression in scrapie susceptible and resistant sheep 2.665
Networks in the brain: from neurovascular coupling of the BOLD effect to brain functional architecture 2.660
The natural course of chronic HBsAg positive hepatitis with serum HBV-DNA and anti-HBe in Sardinia 2.586
Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease 2.495
null 2.446
Oxidative Imbalance in HIV-1 Infected Patients Treated with Antiretroviral Therapy 2.433
null 2.280
Lipid derangement and prion misfolding in prion infected mouse neuroblastoma cells lines and in brains and skin fibroblasts from scrapie-susceptible sheep 2.279
null 2.267
Thalassemia intermedia is associated with a proatherogenic biochemical phenotype 2.145
Systemic alteration of Cholesterol Homeostasis in experimental and natural scrapie 2.103
null 2.100
Physical Performance and Falling Risk Are Associated with Five-Year Mortality in Older Adults: An Observational Cohort Study 2.067
null 2.030
null 1.971
Epidemiology of HDV infection in Sardinia, an island with a high endemicity for HBV: A multicenter study 1.908
null 1.848
Studio ecografico dei linfonodi del legamento epatoduodenale in pazienti con epatite cronica virale 1.789
New method for early detection of CNS damage in elderly subjects: abnormal lipid accumulation and cluster formation in naive PBMCs 1.786
null 1.769
Epidemiology of infection with HIV-1 in Sardinia: a multicentre prospective study 1.700
null 1.660
Molecular epidemiology of intrafamilial transmission of hepatitis C virus: A controlled study 1.651
Multidimensional geriatric assessment in elderly HIV patients 1.623
null 1.601
Immunological aspects in anti-HIV seronegative drug addicts. Correlation with the duration of heroin addiction and other viral infections 1.565
null 1.527
RBANS: un valido strumento di valutazione cognitiva in soggetti HIV-infetti in cART = RBANS: a valid tool for cognitive assessment of HIV-infected people on cART 1.484
null 1.450
The Role of Peripheral Cells in Neurocognitive Disorders Detection 1.446
[Immunological aspects in anti-HIV seronegative drug addicts. Correlation with the duration of heroin addiction and other viral infections]. FT Aspetti immunologici nei tossicodipendenti anti-HIV sieronegativi. Correlazione con la durata di assunzione dell'eroina e con altre infezioni virali. 1.368
Prevalenza e caratteristiche cliniche dell’infezione delta in emodializzati portatori cronici di HBsAg 1.359
null 1.355
The hidden treasure of 24-hours ambulatory blood pressure monitoring—Assessing BP variability 1.327
null 1.320
The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders 1.296
Prevalence and clinical significance of serum HBV-DNA in the course of anti-HBe positive chronic hepatitis B in Sardinia 1.289
Correlation between depressive symptoms and cognitive impairment and use of hmg-coa reductase inhibitors in a group of elderly subjects evaluated in their own homes 1.264
Cholesterol esterification during differentiation of mouse erythroleukemia (Friend) cells 1.239
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 1.214
Epidemiologia dell’infezione da HIV a Cagliari: studio multicentrico 1.191
Prevalenza e significato clinico dell’HBV-DNA nel siero dei portatori cronici di HBsAg/anti-HBe positivi in Sardegna 1.168
null 1.158
Aspetti immunologici nei tossicodipendenti anti-HIV sieronegativi. Correlazione con la durata di assunzione dell’eroina e con altre infezioni virali 1.133
null 1.112
Epidemiologic patterns of infection with HIV in Sardinia. A multicentre study 1.098
null 1.003
Emergency department: risk stratification in the elderly 998
Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population 986
High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment 958
Valutazione multidimensionale geriatrica: confronto tra un gruppo di anziani valutati ambulatorialmente e un gruppo di anziani valutati a domicilio 919
null 919
null 915
null 914
Comprehensive Geriatric Assessment: Application and correlations in a real-life cross-sectional study 867
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 847
null 803
null 742
null 706
Mini-Mental State Examination: Optimal Cut-Off Levels for Mild and Severe Cognitive Impairment 706
null 683
Long-term effect of lymphoblastoid interferon therapy of anti-HBe and HBV-DNA positive chronic hepatitis B 671
How to evaluate Quality of Life 670
Pharmacologic cholesterol homeostasis affects prion generation in a synergistic manner 641
Association between Depressive Mood, Antidepressant Therapy and Neuropsychological Performances: Results from a Cross-Sectional Study on Elderly Patients 620
In vitro synergistic anti-prion effect of cholesterol ester modulators in combination with chlorpromazine and quinacrine 613
Cognitive assessment with neurocognitive screening tools 604
Favourable response to lymphoblastoid interferon of anti-HBe positive chronic Hepatitis type B 596
Valutazione multidimensionale geriatrica di un gruppo di anziani ultraottantacinquenni studiati nel proprio domicilio 590
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 587
Diabetes mellitus, malnutrition, and sarcopenia: The bond is not explained by bioelectrical impedance analysis in older adults 580
MMSE e MODA due metodiche a confronto nello screening del deficit cognitivo nel soggetto anziano valutato sul territorio: dati preliminari 579
Treatment of chronic delta hepatitis with higt and low doses of interferon alpha-2a. A randomizzed controlled trial 567
Nutritional Status and Potentially Inappropriate Medications in Elderly: Real-World Experience 557
Fragilità: confronto tra un gruppo di anziani valutati nel proprio domicilio e un gruppo di anziani valutati ambulatorialmente 538
Valutazione multidimensionale di una popolazione di anziani fragili: correlazione del PPT con le altre aree dimensionali 537
null 528
Valutazione dello stato nutrizionale di una popolazione di soggetti anziani: correlazione del MNA con altre aree dimensionali 528
Cholesterol esterification as a mediator of proliferation of vascular smooth muscle cells and peripheral blood mononuclear cells during atherogenesis 526
STOPP/START antiaggregation and anticoagulation alerts in atrial fibrillation 523
Variazioni della massa ossea nei pazienti con b Talassemia major in trattamento con calcio, Vitamina D e bisfosfonati. 523
Cholesterol homeostasis: a key to prevent or slow down neurodegeneration 519
The response to lymphoblastoid interferon of anti-HBe and HBV-DNA positive patients with chronic hepatitis B 517
Randomized controlled trial of high and low doses of interferon (IFN) alpha-2a (Roferon-A) in chronic HDV hepatitis 511
L'Interferone nella terapia dell’epatite cronica delta 510
Efficacia e tollerabilità della terapia antiretrovirale altamente attiva (HAART) negli over 60: descrizione di 3 casi clinici 509
Valutazione multidimensionale: monitoraggio della fragilità in un gruppo di soggetti ultrasessantacinquenni 507
Anemia in Elderly Patients-The Impact of Hemoglobin Cut-Off Levels on Geriatric Domains 501
Orthogeriatric Assessment of the Elderly Patient with Fragility Hip Fracture: Preliminary Results of a Prospective Study 498
Anti-HBe and HBV-DNA positive chronic hepatiis B: response to interferon therapy 493
Totale 139.348
Categoria #
all - tutte 207.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 207.227


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.133 0 0 0 0 0 0 0 0 0 0 1.684 1.449
2021/20228.463 745 676 614 438 596 555 637 525 645 869 969 1.194
2022/202312.819 1.364 1.702 1.638 1.028 1.067 1.234 560 827 786 891 1.019 703
2023/202415.146 614 615 509 874 1.438 2.704 2.777 994 674 1.145 1.438 1.364
2024/202531.414 6.890 8.509 4.281 3.782 2.367 1.737 2.554 169 324 211 277 313
2025/20267.395 570 479 880 457 617 533 1.112 935 919 887 6 0
Totale 164.935